Q2N0S6 (Q2N0S6_HV1) Human immunodeficiency virus type 1 (HIV-1)
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
860 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
195 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs |
Heteromer | 99.55 | 6×NAG; 3×NAG; 36×NAG; | |||
| Cytoplasmic tail deleted HIV Env trimer in nanodisc |
Heteromer | 99.32 | 6×NAG; 3×NAG; 36×NAG; | |||
| Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion… |
Heteromer | 99.21 | 6×NAG; 9×NAG; 3×NAG; 3×NAG; 9×NAG; 12×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG; | |||
| 3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trime… |
Heteromer | 99.21 | 3×NAG; 6×NAG; 12×NAG; 3×NAG; 9×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting A… |
Heteromer | 99.56 | 3×NAG; 3×NAG; 21×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 24×NAG; | |||
| Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12… |
Heteromer P01834; P01857; S6B291; | 99.56 | 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | |||
| Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody R… |
Heteromer | 99.12 | 19×NAG; 1×NAG; 2×NAG; 27×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.67 | 9×NAG; 2×NAG; 1×NAG; 47×NAG; | |||
| Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) |
Heteromer | 99.24 | 21×NAG; 12×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| Cryo-EM structure of M4008_N1 Fab in complex with BG505 DS-SOSIP.664 Env trimer |
Heteromer | 99.11 | 3×NAG; 15×NAG; 15×NAG; 3×NAG; 21×NAG; | |||
| Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody G… |
Heteromer | 99.12 | 19×NAG; 1×NAG; 2×NAG; 27×NAG; | |||
| Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3) |
Heteromer | 99.24 | 21×NAG; 12×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing bi-specific anti… |
Heteromer | 99.12 | 12×NAG; 4×NAG; 1×NAG; 32×NAG; | |||
| Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab87… |
Heteromer | 96.77 | 3×NAG; 3×NAG; 3×NAG; 18×NAG; 21×NAG; | |||
| BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R |
Heteromer | 97.73 | 18×NAG; 3×NAG; 3×NAG; 39×NAG; | |||
| Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 |
Heteromer | 96.77 | 4×NAG; 3×NAG; 2×NAG; 12×NAG; 30×NAG; | |||
| Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP an… |
Heteromer | 99.12 | 15×NAG; 9×NAG; 6×NAG; 12×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP an… |
Heteromer | 99.12 | 12×NAG; 18×NAG; 6×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV… |
Heteromer | 99.56 | 21×NAG; 6×NAG; 6×NAG; 9×NAG; 9×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.53 | 9×NAG; 1×NAG; 2×NAG; 54×NAG; | |||
| Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2) |
Heteromer | 99.24 | 24×NAG; 12×NAG; 3×NAG; 15×NAG; | |||
| Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP an… |
Heteromer | 99.24 | 21×NAG; 9×NAG; 9×NAG; 3×NAG; 3×NAG; 12×NAG; | |||
| The CryoEM structure of N49-P9.6-FR3 and PGT121 Fabs in complex with BG505 SOSIP.664 |
Heteromer | 99.56 | 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1 |
Heteromer | 97.68 | 3×NAG; 49×NAG; | |||
| Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 En… |
Heteromer | 99.56 | 9×NAG; 9×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab89… |
Heteromer | 96.77 | 16×NAG; 10×NAG; 2×NAG; 1×NAG; 22×NAG; | |||
| Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab27… |
Heteromer | 96.77 | 16×NAG; 2×NAG; 4×NAG; 29×NAG; | |||
| Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex |
Heteromer P01730; | 99.19 | 3×NAG; 6×NAG; | |||
| Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… |
Heteromer | 98.67 | 6×NAG; 12×NAG; 6×NAG; 6×NAG; 3×NAG; 6×NAG; 9×NAG; | |||
| Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L |
Heteromer | 94.37 | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 12×NAG; | |||
| Crystal structure of the cleavage-independent prefusion HIV Env glycoprotein trimer of the clade A … |
Heteromer | 99.78 | 3×NAG; 6×NAG; 9×NAG; 6×NAG; 9×NAG; 3×NAG; 3×MAN; 3×BMA; 36×NAG; 6×MAN; | |||
| Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074… |
Heteromer | 99.27 | 1×NAG; 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 2×MAN; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×FUC; | |||
| HIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022 |
Heteromer | 96.38 | 6×NAG; 12×NAG; 3×NAG; 6×NAG; 3×NAG; 21×NAG; | |||
| HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-4… |
Heteromer | 98.44 | 9×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 33×NAG; | |||
| HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 |
Heteromer Q6PJF2; Q8N355; S6B2B6; S6C4S0; | 95.7 | 7×NAG; 3×NAG; 2×NAG; 2×NAG; 1×NAG; 27×NAG; | |||
| BG505 SOSIP.664 Trimer |
Heteromer | 99.09 | 12×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 33×NAG; | |||
| BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs |
Heteromer | 98.89 | 30×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
| HIV-1 Env (BG505 SOSIP.664) in complex with the IgA bNAb 7-269 and the antibody 3BNC117. |
Heteromer | 99.55 | 19×NAG; 3×NAG; 5×NAG; 10×NAG; 3×NAG; 1×NAG; 3×NAG; 20×NAG; | |||
| Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusi… |
Heteromer | 99.09 | 9×NAG; 6×NAG; 82×NAG; | |||
| Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer | 99.19 | 8×NAG; 22×NAG; 6×NAG; 5×NAG; 25×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO GPZ6-a.01 FAB |
Heteromer | 99.11 | 3×NAG; 6×NAG; 48×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.53 | 18×NAG; 2×NAG; 1×NAG; 1×NAG; 39×NAG; | |||
| Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB |
Heteromer | 99.09 | 18×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Cryo-EM structure of BG505 Env mutant A517E in complex with antibody ACS202 Fab |
Heteromer | 92.09 | 33×NAG; 9×NAG; 6×NAG; 3×NAG; 12×NAG; | |||
| CNE55.664 trimer in complex with broadly neutralizing HIV antibody PGT145 |
Heteromer | 99.56 | 25×NAG; 5×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 20×NAG; | |||
| Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 |
Heteromer | 99.17 | 6×NAG; 15×NAG; 6×NAG; 33×NAG; | |||
| Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB |
Heteromer | 99.09 | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 |
Heteromer | 99.1 | 10×NAG; 4×NAG; 1×NAG; 2×NAG; 1×NAG; 40×NAG; | |||
| BJOX2000.664 trimer in complex with Fab fragment of broadly neutralizing HIV antibody PGT145 |
Heteromer | 99.56 | 25×NAG; 5×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 20×NAG; | |||
| BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 |
Heteromer | 99.55 | 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Cryo-EM Structure of PG9RSH DU025 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer | 99.2 | 17×NAG; 2×NAG; 3×NAG; 1×NAG; 40×NAG; | |||
| Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB |
Heteromer | 99.09 | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 |
Heteromer | 99.56 | 28×NAG; 5×NAG; 1×NAG; 3×NAG; 3×NAG; 3×NAG; 20×NAG; | |||
| BG505.MD39TS Env trimer in complex with Fab from antibody C05 |
Heteromer | 97.52 | 21×NAG; 1×BMA; 3×NAG; 1×NAG; 41×NAG; | |||
| BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1 |
Heteromer | 97.65 | 4×NAG; 2×NAG; 1×NAG; 42×NAG; | |||
| BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2 |
Heteromer | 98.84 | 18×NAG; 3×NAG; 27×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.71 | 7×NAG; 3×NAG; 52×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO HERH-a.01 FAB |
Heteromer | 99.11 | 3×NAG; 6×NAG; 48×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 99.25 | 3×NAG; 6×NAG; 9×NAG; 3×NAG; 36×NAG; 3×83G; | |||
| Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodie… |
Heteromer | 99.19 | 6×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 99.22 | 4×NAG; 1×NAG; 2×NAG; 1×NAG; 11×NAG; 1×JYJ; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 99.25 | 3×NAG; 6×NAG; 9×NAG; 3×NAG; 36×NAG; 3×JYY; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 99.22 | 3×NAG; 6×NAG; 12×NAG; 3×NAG; 30×NAG; 3×JYV; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with … |
Heteromer | 99.21 | 3×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex … |
Heteromer | 99.21 | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to VRC01 FR3-03 scFv in Compl… |
Heteromer | 99.23 | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 99.25 | 3×NAG; 6×NAG; 9×NAG; 3×NAG; 33×NAG; 3×JYS; | |||
| Crystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 Env trimer |
Heteromer | 99.19 | 2×NAG; 5×NAG; 3×NAG; 2×NAG; 2×NAG; 2×NAG; 6×NAG; | |||
| 3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trime… |
Heteromer | 99.21 | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; | |||
| Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin… |
Heteromer S6B291; | 98.66 | 9×NAG; 3×NAG; 18×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
| Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and … |
Heteromer | 97.94 | 6×NAG; 6×NAG; 3×NAG; 12×NAG; 3×NAG; 18×NAG; | |||
| Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 |
Heteromer | 97.56 | 1×NAG; 14×NAG; 6×NAG; 3×NAG; 2×NAG; 31×NAG; | |||
| Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly … |
Heteromer | 100.0 | 9×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; 3×NAG; 3×NAG; 6×NAG; | |||
| Uncleaved prefusion optimized gp140 trimer with an engineered 8-residue HR1 turn bound to broadly n… |
Heteromer | 100.0 | 12×NAG; 6×NAG; 3×NAG; 6×NAG; 9×NAG; 3×NAG; 3×NAG; 12×NAG; | |||
| Cryo-EM Structure of PG9RSH DU011 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer A4F255; Q6PJG0; | 99.2 | 16×NAG; 3×NAG; 3×NAG; 1×NAG; 38×NAG; | |||
| BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 |
Heteromer P0DOX5; Q6GMW3; Q8TCD0; S6B291; | 99.21 | ||||
| BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A) |
Heteromer | 97.08 | 3×NAG; 24×NAG; 39×NAG; | |||
| BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B) |
Heteromer | 97.28 | 3×NAG; 21×NAG; 39×NAG; | |||
| HIV Env BG505_MD39_B16 SOSIP boosting trimer in complex with B16_d77.5 mouse Fab and RM20A3 Fab |
Heteromer | 96.1 | 3×NAG; 3×NAG; 3×NAG; 36×NAG; | |||
| BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragmentantigen binding a… |
Heteromer | 93.58 | 15×NAG; 3×NAG; 3×NAG; 33×NAG; | |||
| Cryo-EM structure of VRC01.23 in complex with HIV-1 Env BG505 DS.SOSIP |
Heteromer | 99.24 | 9×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 36×NAG; | |||
| BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 |
Heteromer | 98.2 | 8×NAG; 1×NAG; 12×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point) |
Heteromer | 98.18 | 36×NAG; 2×NAG; 4×NAG; 17×NAG; | |||
| BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP42 fragmentantigen binding … |
Heteromer | 93.52 | 15×NAG; 3×NAG; 39×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point) |
Heteromer | 97.7 | 26×NAG; 2×NAG; 1×NAG; 27×NAG; | |||
| BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R |
Heteromer | 97.27 | 3×NAG; 12×NAG; 51×NAG; | |||
| Cryo-EM Structure of PGT145 DU303 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer | 99.19 | 14×NAG; 4×NAG; 5×NAG; 35×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point) |
Heteromer | 97.7 | 34×NAG; 3×NAG; 17×NAG; | |||
| BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 97.3 | 3×NAG; 18×NAG; 44×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point) |
Heteromer | 97.72 | 30×NAG; 3×NAG; 24×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point) |
Heteromer | 98.16 | 25×NAG; 3×NAG; 29×NAG; | |||
| Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab |
Heteromer | 99.25 | 3×NAG; 5×NAG; 6×NAG; 1×NAG; 33×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.52 | 20×NAG; 1×NAG; 2×NAG; 42×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point) |
Heteromer | 97.7 | 33×NAG; 1×NAG; 3×NAG; 2×NAG; 13×NAG; | |||
| MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab |
Heteromer | 92.86 | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 51×NAG; | |||
| HIV Env BG505_MD39_B11 SOSIP boosting trimer in complex with B11_d77.7 mouse Fab and RM20A3 Fab |
Heteromer | 96.79 | 3×NAG; 3×NAG; 3×NAG; 45×NAG; | |||
| BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3 |
Heteromer | 95.45 | 3×NAG; 1×NAG; 33×NAG; | |||
| MD65 N332-GT5 SOSIP in complex with RM_N332_08 Fab and RM20A3 Fab |
Heteromer | 92.86 | 6×NAG; 3×NAG; 42×NAG; | |||
| MD65 N332-GT5 SOSIP in complex with RM_N332_36 Fab and RM20A3 Fab |
Heteromer | 92.66 | 6×NAG; 3×NAG; 51×NAG; | |||
| MD65 N332-GT5 SOSIP in complex with RM_N332_32 Fab and RM20A3 |
Heteromer | 92.86 | 3×NAG; 3×NAG; 42×NAG; | |||
| MD65 N332-GT5 SOSIP in complex with RM_N332_07 Fab and RM20A3 Fab |
Heteromer | 92.84 | 6×NAG; 3×NAG; 36×NAG; | |||
| Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer |
Heteromer | 99.54 | 18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 |
Heteromer P01834; Q8TCD0; S6B291; | 99.25 | 10×NAG; 18×NAG; 5×NAG; 3×NAG; 7×NAG; 1×NAG; 13×NAG; | |||
| Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with C… |
Heteromer P01730; | 99.11 | ||||
| Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations … |
Heteromer | 97.72 | 6×NAG; 3×NAG; 27×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 … |
Heteromer | 99.56 | 9×NAG; 21×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Crystal structure of bovine Fab NC-Cow1 in complex with HIV-1 BG505 SOSIP.664, and human Fabs 35022… |
Heteromer | 99.53 | 3×NAG; 6×NAG; 9×NAG; 9×NAG; 12×NAG; 6×NAG; | |||
| BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) |
Heteromer | 99.09 | 16×NAG; 1×NAG; 3×NAG; 31×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.5 | 1×NAG; 5×NAG; 2×NAG; 57×NAG; | |||
| vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer |
Heteromer | 99.09 | 9×NAG; 9×NAG; 3×NAG; 36×NAG; | |||
| Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab |
Heteromer | 99.19 | 21×NAG; 1×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 4×NAG; 23×NAG; | |||
| BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 tim… |
Heteromer | 97.71 | 10×NAG; 3×NAG; 45×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point) |
Heteromer | 98.15 | 31×NAG; 3×NAG; 1×NAG; 20×NAG; | |||
| BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point) |
Heteromer | 98.18 | 30×NAG; 1×NAG; 2×NAG; 23×NAG; | |||
| vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer |
Heteromer | 99.09 | 3×NAG; 12×NAG; 2×NAG; 4×NAG; 35×NAG; | |||
| BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 97.27 | 3×NAG; 24×NAG; 1×NAG; 37×NAG; | |||
| The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Br… |
Heteromer | 99.54 | 24×NAG; 6×NAG; 36×NAG; | |||
| BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 … |
Heteromer | 99.19 | 1×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×NAG; 8×NAG; 2×NAG; 3×NAG; 1×NAG; 34×NAG; | |||
| HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 |
Heteromer Q6PIL8; Q8N355; S6B2B6; | 99.19 | 3×NAG; 18×NAG; 6×NAG; 6×NAG; 3×NAG; 9×NAG; 15×NAG; | |||
| Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations … |
Heteromer | 99.18 | 6×NAG; 3×NAG; 3×NAG; 27×NAG; 3×NAG; 24×NAG; | |||
| BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 97.3 | 3×NAG; 22×NAG; 39×NAG; | |||
| BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab |
Heteromer | 99.07 | 8×NAG; 4×NAG; 2×NAG; 3×NAG; 2×NAG; 24×NAG; | |||
| Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment … |
Heteromer | 99.54 | 9×NAG; 3×NAG; 36×NAG; | |||
| BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 97.08 | 3×NAG; 11×NAG; 49×NAG; | |||
| BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J |
Heteromer | 98.86 | 21×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
| BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F |
Heteromer | 99.3 | 6×NAG; 27×NAG; 21×NAG; | |||
| Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex … |
Heteromer P01730; | 99.45 | 2×NAG; 3×NAG; 24×NAG; | |||
| Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664 |
Heteromer | 99.3 | 1×NAG; 4×NAG; 6×NAG; 5×NAG; 8×NAG; 1×MAN; | |||
| HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylate… |
Heteromer | 99.54 | 12×NAG; 3×NAG; 51×NAG; | |||
| HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab |
Heteromer | 99.54 | 12×NAG; 3×NAG; 51×NAG; | |||
| Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab |
Heteromer | 99.44 | 1×NAG; 1×NAG; 1×NAG; 8×NAG; | |||
| Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex w… |
Heteromer P01730; | 99.45 | 4×NAG; 2×NAG; 1×NAG; 21×NAG; | |||
| HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab |
Heteromer | 99.54 | 12×NAG; 3×NAG; 51×NAG; | |||
| BG505 SOSIP.664 with 2G12 Fab2 |
Heteromer | 99.54 | 3×NAG; 6×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; 21×NAG; | |||
| HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab |
Heteromer | 99.54 | 12×NAG; 3×NAG; 51×NAG; | |||
| HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endog… |
Heteromer | 99.54 | 12×NAG; 3×NAG; 51×NAG; | |||
| Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab |
Heteromer | 99.45 | 7×NAG; 1×NAG; 1×NAG; 1×NAG; 27×NAG; 3×5VG; | |||
| Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) |
Heteromer P01730; Q2N0S5; | 99.44 | 4×NAG; 4×NAG; 1×NAG; 7×NAG; | |||
| Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment … |
Heteromer | 99.53 | 12×NAG; 3×NAG; 27×NAG; | |||
| Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment … |
Heteromer | 99.54 | 3×NAG; 9×NAG; 33×NAG; | |||
| Cryo-EM structure of the HIV-1 BG505 IDL Env trimer in complex with 3BNC117 and 10-1074 Fabs |
Heteromer | 98.87 | 12×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 39×NAG; | |||
| Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly n… |
Heteromer P01730; | 99.5 | 2×NAG; 8×NAG; 11×NAG; 1×NAG; 30×NAG; | |||
| HIV Env BG505 NFL TD+ in complex with antibody E70 fragment antigen binding |
Heteromer | 99.09 | 12×NAG; 3×NAG; 3×NAG; 27×NAG; | |||
| Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precu… |
Heteromer | 99.34 | 1×NAG; 6×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×MAN; | |||
| XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex … |
Heteromer Q2N0S5; | 99.34 | 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with … |
Heteromer Q2N0S5; | 99.56 | 6×NAG; 12×NAG; 9×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG; | |||
| Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with … |
Heteromer Q2N0S5; | 99.56 | ||||
| HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 |
Heteromer A0A1Y1B8B1; P01840; Q2N0S7; | 99.55 | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibo… |
Heteromer Q2N0S7; | 99.11 | 21×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG; | |||
| Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S7; | 99.11 | 4×NAG; 36×NAG; 1×NAG; 2×NAG; 12×NAG; | |||
| Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antib… |
Heteromer Q2N0S9; | 99.12 | 9×MAN; 3×NAG; 6×NAG; 3×NAG; | |||
| Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibo… |
Heteromer Q2N0S7; | 99.11 | 27×NAG; 3×NAG; 9×NAG; | |||
| Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S7; | 99.12 | 3×NAG; 36×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S7; | 99.12 | 9×NAG; 6×NAG; 24×NAG; 3×NAG; 21×NAG; | |||
| HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 |
Heteromer Q2N0S5; | 99.54 | 8×NAG; 2×NAG; 2×NAG; 45×NAG; | |||
| Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elic… |
Heteromer Q2N0S7; | 99.12 | 21×NAG; 9×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG; | |||
| Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicite… |
Heteromer Q2N0S7; | 99.12 | 8×NAG; 12×NAG; 7×NAG; 12×NAG; 3×NAG; 9×NAG; | |||
| Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 En… |
Heteromer Q2N0S7; | 99.12 | 21×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; | |||
| Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 … |
Heteromer Q2N0S7; | 99.12 | 21×NAG; 9×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… |
Heteromer P01857; P04578; P0DOY2; | 99.11 | 6×NAG; 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | |||
| Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 |
Heteromer Q2N0S5; | 99.56 | 33×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; 3×83J; | |||
| HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody F… |
Heteromer Q2N0S7; | 100.0 | 22×NAG; 1×NAG; 2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 22×NAG; | |||
| VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer P0DOX5; Q2N0S7; Q6N089; Q6P5S8; Q8N5F4; | 97.33 | 27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Cryo-EM structure of PGT145 R100aS Fab bound to HIV-1 BG505 DS-SOSIP.664 Env trimer |
Heteromer D0PUM0; | 99.11 | 22×NAG; 2×NAG; 2×NAG; 6×NAG; 3×NAG; 1×NAG; 24×NAG; 1×PO4; | |||
| HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with gp120-Interface pAb from Rh.33203 |
Heteromer D0PUM0; | 97.58 | 23×NAG; 3×NAG; 1×NAG; 40×NAG; | |||
| Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment |
Heteromer Q2N0S7; | 99.54 | 18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO DJ85-c.01 FAB |
Heteromer Q2N0S5; | 99.09 | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO DJ85-b.01 FAB |
Heteromer Q2N0S5; | 99.09 | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO DJ85-e.01 FAB |
Heteromer Q2N0S5; | 99.09 | 24×NAG; 3×NAG; 18×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO DJ85-d.01 FAB |
Heteromer Q2N0S5; | 99.09 | 24×NAG; 3×NAG; 18×NAG; | |||
| VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer Q2N0S9; Q6N095; Q6PIL8; | 98.41 | 3×NAG; 21×NAG; 12×NAG; 15×NAG; | |||
| CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO HERH-c.01 FAB |
Heteromer Q2N0S5; | 99.09 | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | |||
| BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3 |
Heteromer D0PUM0; | 97.51 | 5×NAG; 1×NAG; 1×NAG; 26×NAG; | |||
| BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4 |
Heteromer D0PUM0; | 97.69 | 3×NAG; 3×NAG; 55×NAG; | |||
| Cryo-EM structure of PGDM1400 Fab bound to HIV-1 BG505 DS-SOSIP.664 Env trimer |
Heteromer D0PUM0; | 99.11 | 2×NAG; 18×NAG; 1×NAG; 3×NAG; 1×NAG; 33×NAG; | |||
| HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with V5, gp120-Interface, and Anti-Immune Complex p… |
Heteromer D0PUM0; | 97.58 | 1×NAG; 17×NAG; 1×NAG; 2×NAG; 1×NAG; 43×NAG; | |||
| HIV CH505/BG505 SOSIP.v8.1 Env in Complex with V1/V3 Epitope and Anti-Immune Complex pAbs from Rabb… |
Heteromer A0A6H1VLP0; | 87.62 | 14×NAG; 3×NAG; 2×NAG; 1×NAG; 38×NAG; | |||
| HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with V5 pAb from Rh.33203 |
Heteromer D0PUM0; | 97.57 | 25×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 31×NAG; | |||
| Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG5… |
Heteromer Q2N0S9; | 99.34 | 15×NAG; 3×NAG; 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 24×NAG; | |||
| Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefus… |
Heteromer Q2N0S9; | 99.34 | 3×NAG; 3×NAG; 3×NAG; 36×NAG; | |||
| BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3 |
Heteromer D0PUM0; | 97.66 | 3×NAG; 3×NAG; 50×NAG; | |||
| BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding |
Heteromer Q2N0S8; | 98.16 | 3×NAG; 15×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
| MD64 N332-GT5 SOSIP |
Heteromer Q2N0S8; | 93.46 | 3×NAG; 33×NAG; | |||
| BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289 |
Heteromer D0PUM0; | 97.65 | 2×NAG; 3×NAG; 43×NAG; | |||
| BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding |
Heteromer Q2N0S5; | 94.09 | 18×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
| Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin… |
Heteromer | 99.76 | 12×NAG; 3×NAG; 3×MAN; 30×NAG; | |||
| Cryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabs |
Heteromer | 99.76 | ||||
| cryoEM reconstruction of the HIV gp140 in complex with the extracellular domains of CD4 and the adn… |
Heteromer P01730; | 99.44 | ||||
| Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs |
Heteromer | 99.22 | 4×NAG; 9×NAG; 1×NAG; 1×NAG; 1×NAG; 1×MAN; 30×NAG; | |||
| BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3 |
Heteromer | 99.2 | 3×NAG; 3×NAG; 42×NAG; | |||
| Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 |
Heteromer A0A6H1VH54; | 99.19 | 1×NAG; 3×NAG; 1×NAG; 5×NAG; | |||
| Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 |
Heteromer A0A1W6IPB2; | 99.21 | 27×NAG; 9×NAG; 3×NAG; 18×NAG; | |||
| ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs |
Heteromer | 97.5 | 10×NAG; 3×NAG; 2×NAG; 1×NAG; 3×NAG; 3×NAG; 41×NAG; | |||
| Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer | homo-6-mer | 99.56 | 3×NAG; 6×NAG; 45×NAG; | |||
| Cryo-EM structure of BG505 SOSIP trimer purified via Galanthus nivalis lectin chromatography | homo-3-mer | 99.13 | 27×NAG; 5×NAG; 1×NAG; 25×NAG; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7n6u.1.A | homo-3-mer | 0.59 | 1×NAG; | 76.22 | ||